News & Updates

Individuals with nonalcoholic fatty liver disease (NAFLD) – despite having a lean body or healthy BMI – are at an elevated risk for peripheral vascular disease, stroke, and cardiovascular disease (CVD), a finding that surprises gastroenterologists and researchers at DDW 2022.

Increasing bodyweight may aggravate cardiovascular risk in patients with type 2 diabetes (T2D), a recent Japan study has found.

Drinking a little amount of whey protein before meals helps keep a lid on blood glucose levels of individuals with type 2 diabetes (T2D), as shown in a study.

Among older Southeast Asian type 2 diabetes mellitus patients, severe hypoglycaemia tends to occur with tighter glycaemic control, greater impaired hypoglycaemia awareness, and higher worry scores, regardless of treatment regimens, according to a study.

The use of hormonal replacement therapy (HRT) among postmenopausal women may be associated with a reduced risk of mortality after a COVID-19 diagnosis, according to a retrospective study from Sweden.

Treatment with eldecalcitol, an active vitamin D analogue, does not result in a significant reduction in diabetes incidence and has failed to improve the rate of regression to normoglycaemia relative to placebo among patients with impaired glucose tolerance at high risk for type 2 diabetes (T2D), results of a study have shown.